08:01 AM EDT, 10/29/2025 (MT Newswires) -- Bausch + Lomb ( BLCO ) , up 8.5% in U.S. pre-market, said Wednesday that third-quarter adjusted income and revenue both rose, beating estimates.

The vision care company said adjusted income jumped to US$66 million, or $0.18 per share, from $46 million, or $0.13 per share, last year. Analysts polled by FactSet had expected $0.16 per share.

Total reported revenue rose 7% to $1.28 billion from $1.2 billion, beating the $1.27 billion forecast.

Bausch + Lomb ( BLCO ) also updated its fiscal 2025 adjusted EBITDA to $870 million to $910 million, from $860 million to $901 million.

"We're delivering on the vision we laid out in 2023, with a base business engine that continues to hum and steady introduction of innovative products across categories," said Brent Saunders, board chair and chief executive officer. Saunders said the company's "loaded and differentiated pipeline" of clinical-stage programs will be highlighted at the next investor day in a few weeks.

Bausch + Lomb ( BLCO ) shares are up $1.29, to $16.49 in New York trading,